基因泰克（Genentech, a member of Roche Group）

个人简介: 郝志奇拥有超过20年在生物技术和仪器行业的经验，她专注于蛋白质治疗药物的CMC开发以及质谱技术在生物制药产品中的应用。她在分析开发和质量控制方面拥有深厚的专业知识，支持包括单克隆抗体、双特异性抗体、融合蛋白和抗体偶联药物（ADC）在内的多种蛋白质治疗药物的早期和晚期开发。郝志奇是质谱技术应用在蛋白质、肽、核酸及蛋白质组学领域的公认专家。她拥有丰富的实践经验，领导将多属性分析方法（MAM）等前沿技术应用于受监管的质量控制环境中。她的科学贡献体现在多篇学术出版物、受邀于学术机构及国内外会议的演讲，以及荣获美国药物科学家协会颁发的生物技术创新奖。With over 20 years of experience in biotechnology and instrumentation industry, Zhiqi’s contribution is focused on CMC development for protein therapeutics and the application of mass spectrometry technologies for biopharmaceutical characterization. She possesses deep expertise in analytical development and quality control, supporting both early- and late-stage development of diverse protein therapeutics, including mAbs, bispecifics, fusion proteins, and ADCs. Zhiqi is a recognized authority in mass spectrometry-based characterization of proteins, peptides, nucleic acids, and proteomics. She has extensive hands-on experience leading the implementation of cutting-edge technologies—such as the multi-attribute method (MAM)—in regulated quality control (QC) environments. Her scientific contributions are reflected in peer-reviewed publications, invited talks at academic institutions and national and international conferences, and recognition as the recipient of The Innovation in Biotechnology Award from the American Association of Pharmaceutical Scientists. 查看更多